Galena Biopharma licenses cancer pain drug Abstral

by admin on March 18, 2013

Galena Biopharma Inc. said Monday it acquired the U.S. rights to a fast-acting drug designed to treat severe pain in cancer patients.Galena is acquiring a drug called Abstral from Orexo AB of Sweden. Abstral …

View full post on pain – Yahoo! News Search Results

Previous post:

Next post: